SCHEMBL6151182

SCHEMBL6151182

Nc1ccc(N2CCNCCN(c3ccc(N)cc3)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 7/20 0.61
MAPT P10636 5/20 0.61
ALDH1A1 P00352 4/20 0.61
KDM4E B2RXH2 4/20 0.61
GFER P55789 4/20 0.61
HTR3E A5X5Y0 3/20 0.61
HTR3B O95264 3/20 0.61
HTR3A P46098 3/20 0.61
HTR3D Q70Z44 3/20 0.61
HTR3C Q8WXA8 3/20 0.61
SIGMAR1 Q99720 3/20 0.61
GAA P10253 3/20 0.61
LMNA P02545 3/20 0.61
HTT P42858 2/20 0.61
KMT2A Q03164 2/20 0.61
MAPK1 P28482 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
ADRA2C P18825 1/20 0.61
PTK2B Q14289 1/20 0.61
ESR2 Q92731 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6152907 0.98 MAPT (0.61) ADRB1MAPTALDH1A1KDM4EGFER
SCHEMBL531923 0.98 ADRB1 (0.63) ADRB1MAPTALDH1A1KDM4EGFER
SCHEMBL12832086 0.96 ADRB1 (0.61) ADRB1MAPTALDH1A1KDM4EGFER
Hydrochloric Acid SCHEMBL3236795 0.96 ALDH1A1 (0.63) ADRB1MAPTALDH1A1KDM4EGFER
Piperazine SCHEMBL28708983 0.96 ADRB1 (0.61) ADRB1MAPTALDH1A1KDM4EGFER
SCHEMBL6151619 0.96 ADRB1 (0.61) ADRB1MAPTALDH1A1KDM4EGFER
SCHEMBL2319970 0.90 ALDH1A1 (0.62) ADRB1MAPTALDH1A1KDM4EGFER
Hydrochloric Acid SCHEMBL3214287 0.88 ALDH1A1 (0.66) ADRB1MAPTALDH1A1KDM4EGFER
SCHEMBL23347931 0.86 MAPT (0.77) MAPTALDH1A1KDM4EGFERGAA
SCHEMBL7043679 0.86 MAPT (0.77) MAPTALDH1A1KDM4EGFERGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050120494-A1 Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres L'OREAL S.A. (FR) 2005-06-09 US claimed
EP-1518860-A1 Triazacyclononane derivatives substituted on at least one of the nitrogene atoms by a 4-aminophenyle group for dyeing keratinic fibres L'OREAL (FR) 2005-03-30 EP claimed
US-20050120494-A1 Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres L'OREAL S.A. (FR) 2005-06-09 US disclosed
EP-1518860-A1 Triazacyclononane derivatives substituted on at least one of the nitrogene atoms by a 4-aminophenyle group for dyeing keratinic fibres L'OREAL (FR) 2005-03-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050120494-A1 Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres KRT18, TUBB6, TUBB1 ADRB1 3709/4885MAPT 945/4885ALDH1A1 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.